| 000 | 01865 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250516225538.0 | ||
| 264 | 0 | _c20150624 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1559-0100 | ||
| 024 | 7 |
_a10.1007/s12020-014-0349-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPepe, J | |
| 245 | 0 | 0 |
_aEffect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study. _h[electronic resource] |
| 260 |
_bEndocrine _cNov 2014 |
||
| 300 |
_a456-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
| 650 | 0 | 4 |
_aBone Diseases, Metabolic _xblood |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 |
_aCholecalciferol _xpharmacology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypogonadism _xblood |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xblood |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xblood |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRisedronic Acid |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aIsidori, A M | |
| 700 | 1 | _aFalciano, M | |
| 700 | 1 | _aIaiani, G | |
| 700 | 1 | _aSalotti, A | |
| 700 | 1 | _aDiacinti, D | |
| 700 | 1 | _aDel Fiacco, R | |
| 700 | 1 | _aSbardella, E | |
| 700 | 1 | _aCipriani, C | |
| 700 | 1 | _aPiemonte, S | |
| 700 | 1 | _aRaimo, O | |
| 700 | 1 | _aBiondi, P | |
| 700 | 1 | _aBiamonte, F | |
| 700 | 1 | _aLenzi, A | |
| 700 | 1 | _aMinisola, S | |
| 773 | 0 |
_tEndocrine _gvol. 47 _gno. 2 _gp. 456-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12020-014-0349-0 _zAvailable from publisher's website |
| 999 |
_c24080755 _d24080755 |
||